Skip to content
ClinCalc Pro
Menu
Non-selective NSAID

Indomethacin

Brand names: Indocid

Indomethacin is a potent indole NSAID used in orthopaedics for acute gout, ankylosing spondylitis, acute musculoskeletal inflammation and sometimes for prophylaxis of heterotopic ossification.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

It is a strong non-selective cyclo-oxygenase inhibitor, markedly reducing prostaglandin synthesis to control inflammation and pain.

Prescribing in practice

  • It has a high rate of gastrointestinal and central nervous system adverse effects (notably headache, dizziness and confusion, especially in the elderly), so reserve it and use the lowest effective dose for the shortest time.
  • Avoid in active peptic ulceration, significant renal or hepatic impairment, heart failure and the third trimester of pregnancy.
  • Caution with anticoagulants, antiplatelets, diuretics, ACE inhibitors and lithium owing to bleeding, renal and drug-level interactions.

Monitoring

Monitor renal function, blood pressure and for gastrointestinal and CNS adverse effects, particularly in older patients.

Counselling the patient

  • Take with food; report stomach pain, black stools or vomiting blood.
  • Tell your prescriber about headaches, dizziness or confusion.
  • Use only for the short course prescribed.

Evidence & guidelines

MHRA advice on NSAIDs supports lowest-effective-dose, shortest-duration use, with indomethacin recognised for a higher adverse-effect burden than many alternatives.

Reference: NICE CG177 (Gout); BOA/BSSH HO prevention guidelines; SPC Indocid; Cochrane Review (NSAIDs for HO prevention); Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.